General Information of the Compound
Compound ID
CP0555205
Compound Name
5-pyridin-2-yl-2-quinazolin-4-yl-1,2,4-triazol-3-amine
    Show/Hide
Structure
Formula
C15H11N7
Molecular Weight
289.302
Canonical SMILES
Nc1nc(nn1-c1ncnc2ccccc12)-c1ccccn1
    Show/Hide
InChI
InChI=1S/C15H11N7/c16-15-20-13(12-7-3-4-8-17-12)21-22(15)14-10-5-1-2-6-11(10)18-9-19-14/h1-9H,(H2,16,20,21)
    Show/Hide
InChIKey
GUQUFGYMZVYYFU-UHFFFAOYSA-N
Physicochemical Property
logP
1.8547
Rotatable Bonds
2
Heavy Atom Count
22
Polar Areas
95.4
Hydrogen Bond Donor Count
1
Hydrogen Bond Acceptor Count
7
Complexity
22

"RO5" indicates the cutoff set by lipinski's rule of five:

(1) Molecular weight less than 500 Dalton;

(2) xlogp less than 5;

(3) No more than 5 hbonddonor (Hydrogen Bond Donor Count);

(4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count);

(5) No more than 10 rotbonds (Rotatable Bond Count).

    Show/Hide
Click to Show/Hide the External Link(s) of This Compound
PubChem ID
CID: 127042474
ChEMBL ID
CHEMBL3764187
Map of Molecular Bioactivity Related to the Compound
Map of Molecular Bioactivity Related to the Compound

Compound
Cell Line
Protein

Bioactivity Value:

<= 0.1 μM
> 0.1 μM and <= 10 μM
> 10 μM
Imprecise Activity
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT01902, Serine-protein kinase ATM
Cell-based Assay
Cell Line ID Cell Line Name Cell Line Organism
CL000083 MCF-7 Homo sapiens (Human)  1
1
IC50 > 40000 nM
   TI
   LI
   LO
   TS